|Identification of proteins binding to interferon-inducible transcriptional enhancers in hematopoietic cells.
|Purification and characterization of proximal sequence element-binding protein 1, a transcription activating protein related to Ku and TREF that binds the proximal sequence element of the human U1 promoter.
|The autoantigen Ku is indistinguishable from NF IV, a protein forming multimeric protein-DNA complexes.
|Isolation and characterization of cDNA encoding the 80-kDa subunit protein of the human autoantigen Ku (p70/p80) recognized by autoantibodies from patients with scleroderma-polymyositis overlap syndrome.
|cDNA-derived amino acid sequence of the 86-kDa subunit of the Ku antigen.
|Purification of the sequence-specific transcription factor CTCBF, involved in the control of human collagen IV genes: subunits with homology to Ku antigen.
|Human DNA helicase II: a novel DNA unwinding enzyme identified as the Ku autoantigen.
|DNA-dependent ATPase from HeLa cells is related to human Ku autoantigen.
|Non-histone protein 1 (NHP1) is a member of the Ku protein family which is upregulated in differentiating mouse myoblasts and human promyelocytes.
|The interaction between Ku antigen and REF1 protein mediates negative gene regulation by extracellular calcium.
|DNA-dependent protein kinase phosphorylation sites in Ku 70/80 heterodimer.
|Structure of the Ku heterodimer bound to DNA and its implications for double-strand break repair.
|Regulation of osteocalcin gene expression by a novel Ku antigen transcription factor complex.
|Complete sequencing and characterization of 21,243 full-length human cDNAs.
|DNA-dependent protein kinase (DNA-PK) phosphorylates nuclear DNA helicase II/RNA helicase A and hnRNP proteins in an RNA-dependent manner.
|Positive and negative modulation of the transcriptional activity of the ETS factor ESE-1 through interaction with p300, CREB-binding protein, and Ku 70/86.
|The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).
|Systematic identification and analysis of mammalian small ubiquitin-like modifier substrates.
|Conserved modes of recruitment of ATM, ATR and DNA-PKcs to sites of DNA damage.
|APLF (C2orf13) is a novel human protein involved in the cellular response to chromosomal DNA strand breaks.
|A novel human AP endonuclease with conserved zinc-finger-like motifs involved in DNA strand break responses.
|Lysine acetylation targets protein complexes and co-regulates major cellular functions.
|Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.
|Ku is a 5'-dRP/AP lyase that excises nucleotide damage near broken ends.
|Initial characterization of the human central proteome.
|Systematic analysis of protein pools, isoforms, and modifications affecting turnover and subcellular localization.
|The E3 ligase RNF8 regulates KU80 removal and NHEJ repair.
|Deformed epidermal autoregulatory factor-1 (DEAF1) interacts with the Ku70 subunit of the DNA-dependent protein kinase complex.
|Toward a comprehensive characterization of a human cancer cell phosphoproteome.
|An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.
|A human short open reading frame (sORF)-encoded polypeptide that stimulates DNA end joining.
|Mapping of SUMO sites and analysis of SUMOylation changes induced by external stimuli.
|DNA repair. PAXX, a paralog of XRCC4 and XLF, interacts with Ku to promote DNA double-strand break repair.
|Interactome analysis identifies a new paralogue of XRCC4 in non-homologous end joining DNA repair pathway.
|DNA-dependent protein kinase (DNA-PK) permits vascular smooth muscle cell proliferation through phosphorylation of the orphan nuclear receptor NOR1.
|XLS (c9orf142) is a new component of mammalian DNA double-stranded break repair.
|N-terminome analysis of the human mitochondrial proteome.
|Heat shock factor 1, an inhibitor of non-homologous end joining repair.
|The RNF138 E3 ligase displaces Ku to promote DNA end resection and regulate DNA repair pathway choice.
|Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation.
|HEXIM1 and NEAT1 Long non-coding RNA form a multi-subunit complex that regulates DNA-mediated innate immune response.
|Regulation of DNA repair pathway choice in S and G2 phases by the NHEJ inhibitor CYREN.